Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
24 October 2016
Deals | France | M&A | Private Equity
Gide has advised Innovation Capital on its investment in Kayentis during a global round of financing amounting to EUR 3.6 million, alongside Extens. Based in Grenoble and established in 2009, Kayentis is a specialist in eCOA solution for patients and the collection of data in clinical trials. The company has developed a full range of services and broadened its solutions portfolio to serve the pharmaceuticals industry, biotechnology laboratories and CROs. Drawing on its experience in over 120 clinical trials in 75 countries (6,000 sites and 50,000 patients) and a significant number of therapeutic areas, Kayentis adds value to the quality of data and to the efficiency of clinical trials through innovative and intuitive solutions. Its two main development priorities are Patient Commitment and Risk-based Monitoring.
Gide's team comprised partner David-James Sebag and Diane Jouffroy.
